Full PDF Version of the March 2012 Issue

Published: Thursday, Mar 22, 2012

The International Journal of Targeted Therapies in Cancer is focused on the use of targeted therapies and personalized medicine—one of the most rapidly growing and clinically challenging areas of oncology today.

This issue contains articles on:

  • What Turns a Good Cell Bad?
  • Breast Cancer: Beyond Herceptin
  • Melanoma: Are You Ready for PI3K/Akt Inhibitors?
  • A Better Understanding of the SCK/KIT Pathway
  • Lung Cancer: When Targeted Therapies Don’t Work
  • Basal Cell Carcinoma: Hedgehog Speeds Along
  • Myeloproliferative Neoplasms: The Many Possibilities of JAK Inhibition



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Bridging the Gaps Around Oncology Biosimilars: Assessing the Potential Impact of Emerging Agents to PracticeSep 29, 20181.5
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x